Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry
Recruiting
Observational Study
Coronary Artery Disease
Microvascular Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Johannes Gutenberg University Mainz · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* clinical indication to coronary angiography
Exclusion Criteria:
* none
Contacts
Tommaso Gori, PhD, Dott medicina e Chirurgia
+49 6131 172829
tommaso.gori@unimedizin-mainz.de
CONTACT